Note 10 - Share-based Compensation - Schedule of Allocated Expense (Details) - USD ($) |
3 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Share-based compensation expense | $ 757,605 | $ 2,674,105 |
| FC2 Female Condom [Member] | Discontinued Operations, Disposed of by Sale [Member] | ||
| Share-based compensation expense, discontinued operations | 0 | (10,049) |
| General and Administrative Expense [Member] | ||
| Share-based compensation expense | 593,206 | 2,004,716 |
| Research and Development Expense [Member] | ||
| Share-based compensation expense | $ 164,399 | $ 679,438 |
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (benefit) for award under share-based payment arrangement. Excludes amount capitalized. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|